Methylethyl ketoxime ; MEKO; 2-butanone oxime), an antioxidant agent used in paints, resins, and adhesives, was tested for reproductive toxicity in a two-generation study with CD (Sprague-Dawley) rats. Thirty-eight-week-old rats/sex/group (F0) were administered MEKO in water, by gavage, at 0, 10, 100, or 200 mg/kg/day (at a dosing volume of 2 ml/kg), 5 days/week for 10 weeks with vaginal cytology evaluation (VCE) of F0 females during the last 3 weeks of the prebreed period. Animals were mated within groups for 3 weeks with dosing during mating, gestation, and lactation for 7 days/week. F0 parents and Fl weanlings, 10/sex/dose, were necropsied (after a 2-week postwean VCE in F0 females) with hematologic evaluation (including methemoglobin) and histology of adult livers, spleens, and reproductive organs. Fl weanlings, 30/sex/ dose, were dosed for 11 weeks and mated as described above. Because of poor reproductive performance, not treatment related, Fl animals with no F2a litters were rebred to produce F2b litters. Fl parents and F2a weanlings, 10/sex/dose, were necropsied and evaluated as described above. Inguinal mammary glands were examined histologically from all nonselected Fl and F2 (a and b) female weanlings. Adult toxicity was observed in both generations and both sexes at all doses. Treatment-related parental deaths occurred at 200 mg/kg/day. At 100 and 200 mg/kg/day, parents exhibited dose-related reduced body weights and weight gains, reduced feed consumption, clinical signs of toxicity, and anemia with concomitant extramedullary hematopoiesis and hemosiderosis in livers and spleens (and increased spleen weights). At 10 mg/kg/day, only adult liver and spleen histologic effects were present. There was no evidence of reproductive organ or mammary gland pathology or of reproductive or postnatal toxicity at any dose tested. There
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Methylethyl ketoxime (2-butanone oxime; MEKO; CAS No. 96-29-7) is an antioxidant agent, used extensively in paints, resins, adhesives, caulking, and household cleaners. The sum total of production plus importation of MEKO in the U.S. has been estimated to be greater than 5 million pounds per year (U.S. EPA, 1989c) . It is estimated that over 2 million consumers annually are exposed (U.S. EPA, 1987a, b; U.S. Consumer Product Safety Commission, 1985) through use of paints and that 900,000 professional painters may be routinely exposed to MEKO (Stoecklein, 1986) .
The oral LD50 of MEKO in rats is reported to be 2.3 -3.7 g/kg (American Industrial Hygiene Association, 1990) . Although MEKO has been shown to be positive in the mouse lymphoma gene mutation test in the absence, but not in the presence, of liver enzymes, it was negative in several other in vitro and in vivo mutagenicity assays, indicating that MEKO is not mutagenic (RogersBeck et ai, 1988; unpublished results, NTP; Test Rule Studies, U.S. EPA, 1989b) . MEKO was reported to induce hemolytic anemia with compensatory hematopoiesis in a 90-day oral exposure study (American Industrial Hygiene Association, 1990) . Pursuant to the EPA Final Test Rule for methylethyl ketoxime under Section 4 of TSCA (U.S. EPA, 1989b) , this study was performed to evaluate the potential of MEKO administered by gavage to CD rats to produce alterations in parental fertility, maternal pregnancy and lactation, and growth and development of the offspring for two generations, one litter per generation for the F0 to Fl generation and at least one litter per generation in two breedings for the Fl to F2 generation.
METHODS
Test material and dosing solutions. The test material, methylethyl ketoxime (2-butanone oxime; 3 was analyzed at 99% pure 4 (the MEKO Test Rule specified "at least 99%" pure; U.S. EPA, 1989b) with no significant changes in purity over the course of the study. Dosing solutions were formulated in deionized/distilled water at 0.0, 10.0, 100.0, and 200.0 mg/kg/day, corresponding to 0.0, 5.0, 50.0, and 100.0 mg/ml at a dosing volume of 2.0 ml/kg. These doses were based on those employed in a subchronic study in rats to allow direct comparison of endpoints, although the top dose in this study was lower to prevent excessive stress on pregnant females. Dosing formulations were homogeneous and stable for at least 30 days at ambient or refrigerated temperatures and were analyzed for the first four formulations and then at least monthly throughout the study. Formulations were 91.2-109.0% of target concentrations throughout the study. 5 No MEKO was detected in the vehicle control solutions with an estimated detection limit of 0.29 mg/ml.
Animals and husbandry.
Virgin male and female CD (Sprague-Dawley) rats (Crl:CD[SD]BR) VAF/Plus, 6 7 weeks old upon arrival, were housed appropriately 7 and held for a 1-week quarantine with sentinel animals examined for fecal parasites, serum viral antibody titers, and gross necropsy. Animals were suitable for use. All animals were uniquely eartagged. At all times, animals were housed, handled, and treated in conformance with the NIH Guide (NIH, 1985) .
Two hundred forty animals were placed on study, 30/sex/group, by randomization procedures stratified by body weight.
Study design. Eight-week-old rats (designated the F0 generation) were dosed by gavage 8 5 days/week (Monday-Friday) for 10 weeks (prebreed dosing period) with clinical observations taken at and after dosing daily (mortality checks twice daily) and body weights and feed consumption recorded weekly. For the last 3 weeks of the prebreed period, F0 females were evaluated for estrous cyclicity by vaginal lavage. The 5 day per week dosing regimen for the prebreed period was utilized with EPA approval and is not uncommon in reproductive toxicity studies when the route of administration is other than dosed feed or dosed water and ad libitum exposure.
F0 animals were then mated 1:1 within groups for 3 weeks (with a change in unsuccessful partners after 1 week of cohabitation). Dosing for F0 animals was 7 days/week during mating, gestation, and lactation to 3 From AlliedSignal, Inc., Engineered Materials Sector, Morristown, NJ. 4 Analyses included low-resolution mass spectrometry (Finnegan, Model 4500 quadrapole mass spectrometer) and nuclear magnetic resonance spectrometry (Brucker WM-250 NMR Spectrometer) for identity, and capillary gas chromatography and water content (Karl Fischer analysis) for purity.
5 Dosing solutions were analyzed by gas chromatography (Hewlett Packard 5890A GC) using a J and W DB-1 (30 m x 0.32 mm ID) 5-/xm film column and an internal standard of cyclohexanone oxime in methanol.
6 Charles River Breeding Laboratories, Raleigh, NC 7 Individually housed or housed in mating pairs or with litters in solid bottom polycarbonate cages with stainless steel wire lids (Laboratory Products, Rochelle Park, NJ) with Ab-Sorb-Dri cage litter (Laboratory Products, Rochelle Park, NJ), Purina Certified Rodent Chow (Ralston Purina Co , Richmond, IN), and deionized/filtered tap water (City of Durham, Department of Water Resources, Durham, NC) in water bottles available ad libitum throughout the study.
8 Adults were dosed with a 16-gauge 2-inch curved dosing needle; weanlings were dosed with an 18-gauge, 1.5-inch dosing needle (Perfektum, Popper and Sons, New Hyde Park, NY) attached to a syringe of appropriate volume. guarantee exposure to maternal animals during all days of gestation and lactation. Dosing 7 days/week continued for F0 parental animals until scheduled euthanization. Observations of vaginal sperm and/or copulation plug was considered evidence of successful mating (Hafez, 1970) ; the date of insemination was designated Gestational Day (gd) 0. Dams were weighed and feed consumption recorded on gd 0, 7, 14, and 20. The date of parturition was designated Postnatal Day (pnd) 0. Offspring were designated Fl. Dams with litters were weighed and feed consumption recorded on pnd 0, 4, 7, 14, and 21, although maternal feed consumption was unavoidably confounded after pnd 10 by the pups as they began to self feed. Litters were randomly culled to eight (with as equal sex ratio as possible) on pnd 4. At weaning on pnd 21, 30 Fl weanlings/sex/group were randomly selected to be parents of the F2 generation; 10 weanlings/sex/day were randomly selected for hematologic evaluation and necropsy and remaining Fl weanlings were examined externally, euthanized, and discarded (inguinal mammary glands from nonselected Fl female weanlings were examined histologically).
Parental F0 animals were necropsied: males after the mating, females after weaning of their Fl litters and after a 2-week postwean vaginal cytological evaluation for estrous cyclicity. F0 paternal animals, 10/sex/dose, were randomly selected for hematologic evaluation by retroorbital sinus puncture under CO 2 anesthesia (nonfasted).
Fl selected weanlings were dosed 5 days/week for at least 11 weeks. (Dosing was initiated for each selected weanling on pnd 22; the 11-week "formal" prebreed began when the youngest litter was weaned). These Fl animals were then mated as described above with dosing 7 days/week during mating, gestation, and lactation until the demise of the Fl parents. Fl dams and F2 litters were handled as described above for Fl litters. Due to unexpectedly poor Fl reproductive performance, not treatment-or dose-related, Fl mating pairs not successful in producing F2 litters (designated F2a) were rebred (after a 2-week vaginal cytology evaluation for unsuccessful Fl females) with change in partners within groups to produce F2b litters. This additional mating of initially unsuccessful animals follows the suggested approach in the TSCA testing guidelines (U.S. EPA, 1985a) . The decision to rebreed initially unsuccessful Fl parental animals was based on unexpectedly low mating indices: 50.% (15/30), 57.1% (16/28), 63.3% (19/30), and 72.1% (19/26) at 0, 10, 100, and 200 mg/kg/day, respectively. Fertility indices were normal: 93.3% (14 pregnant/15 sperm-positive) at 0 mg/ kg/day and 100% for 10, 100, and 200 mg/kg/day and there were 14, 16, 19, and 19 F2a litters on pnd 0 at 0, 10, 100, and 200 mg/kg/day. Fl males were terminated after the second mating; all Fl females were terminated after a 2-week postwean vaginal cytology evaluation. F2a weanlings, 10/sex/dose, were randomly selected for hematology and necropsy, and mammary glands from remaining F2a females and all F2b females were examined histologically after external examination and termination of the weanlings.
Hematology, necropsy, and histopathology.
Hematologic evaluation of F0 and Fl parents and Fl and F2a weanlings [included, since MEKO induces anemia, as mentioned in the Test Rule (U.S. EPA, 1989b)] consisted of methemoglobin concentration (since formation of methemoglobin is a known consequence of MEKO exposure in test animals), white blood cell (WBC) count (absolute and corrected for nucleated erythrocytes), red blood cell (RBC) count, nucleated RBC count (nRBC), hemoglobin concentration (Hgb), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), platelet count, reticulocyte count, and WBC differential count (segmented neutrophils, band neutrophils, lymphocytes, monocytes, and eosinophils).
F0 and Fl parental necropsy included organ weights as follows (absolute and relative to terminal body weight): testes plus epididymides (males), ovaries (females), liver (both sexes), spleen (both sexes), and pituitary (fixed, both sexes). Histopathologic examination was performed Downloaded from https://academic.oup.com/toxsci/article-abstract/31/2/149/1720467 by guest on 23 February 2019 on the following tissues from high dose and control parental animals: pituitary, ovaries (2), testes (2), vagina, uterus, mammary glands (females), epididymides, seminal vesicles, and prostate; testes, liver, and spleen were examined from parental animals in all groups. Specified histological procedures (U.S. EPA, 1989b) included ovaries serially sectioned at 5 fim, mounting, and staining every 10th section, with 10 sections of each ovary examined for oocyte and follicular morphology Thorgeirsson, 1978, 1979; Pederson and Peters, 1968) ; testes fixed in 10% BNF (buffered neutral formalin), embedded in plastic (GMA; glycol methacrylate), one section through the center cut at 2-3 /i, stained with PAS (periodic acid Schiff)/hematoxylin, and examined for spermatogenic cycle (Lamb and Chapin, 1985; Clermont and Perey, 1957) ; and mammary glands fixed at the ventral region, right and left inguinal mammary glands evaluated histologically (5-fi sections, hematoxylin and eosin stain) for F0 and Fl parental females and Fl and F2 (a and b) nonselected female weanlings.
Statistical analyses. Both parametric and nonparametric statistical procedures were applied to selected measures from this reproductive toxicity study. Parametric evaluations were as follows: Appropriate General Linear Models (GLM) procedures (SAS Institute Inc., 1989a , b, 1990a for the analyses of variance (ANOVA) were employed. Prior to GLM analysis, an arcsinesquare root transformation was performed on all litter-derived percentage data (Snedecor and Cochran, 1967 ) and Bartlett's test for homogeneity of variance (alpha level = 0.001) was performed on all data to be analyzed by ANOVA (Winer, 1962) . GLM analyses were used to determine the significance of the dose-response relationship (test for linear trend) and to determine whether significant dose effects had occurred for selected measures (ANOVA). When a significant {p < 0.05) main effect for dose occurred, Dunnett's multiple comparison test (Dunnett, 1955 (Dunnett, , 1964 ) was used to compare each chemical exposed group to the vehicle control group for that measure. A one-tailed test (i.e., Dunnett's test) was used for all pairwise comparisons except for adult body and organ weight parameters, maternal feed consumption, pup body weight, and percentage males per litter, for which a two-tailed test was used. Nominal scale measures were analyzed by the x 2 test for independence for differences among treatment groups, and by a test for linear trend on proportions (Snedecor and Cochran, 1967) . When x 2 revealed significant (p < 0.05) differences among groups, then a one-tailed Fisher's exact probability test was used for pairwise comparisons between each treated group and the vehicle control group.
Nonparametric data were statistically evaluated using the Kruskal-Wallis one-way analysis of variance by ranks (Siegel, 1956 ) to test for differences among dose groups. Whenever the result of a Kruskal-Wallis test was significant (p < 0.05), the Mann-Whitney U test was used to make individual comparisons between vehicle and chemical dose groups for that measure Siegel, 1956 ). Jonckheere's test for k independent samples (Jonckheere, 1954) was used to identify significant dose-response trends for these parameters.
RESULTS

Parental Parameters
At 200 mg/kg/day, treatment-related mortality was observed in males and females of both generations: 4/30 (13.3%) in FO males, including 3 which died during the prebreed period (excluding an additional FO male which died during this period due to an intubation accident) and 1 which died during the mating period; 11/30 (36.7%) in FO females, all of which died during the prebreed period (no intubation accidents); 15/30 (50.0%) in Fl males, including 8 during the prebreed period, 1 during the first breed, 3 during the interbreed period prior to the second breed, and 3 during the second breed (no intubation accidents); and 8/30 (26.7%) in Fl females, including 4 during the prebreed period, 3 during the vaginal cytology " The epididymides, liver, kidneys, urinary bladder, pituitary, prostate, seminal vesicles, and testes were examined from top dose and control animals. When it was apparent that possible treatment-related lesions were present in testes, spleens, and livers at the top dose, these organs from mid and low dose males were also examined histologically.
b Number of males with the indicated finding. c These males died on study during the prebreed dosing period, as young animals.
associated with the first breed, and 1 during the lactation of her F2b litter (no intubation accidents). In addition, both sexes in both generations exhibited significant reductions in body weights and weight gains during their prebreed exposure periods (Fig. 1 ). There were also occasional significant changes in feed consumption (decreased The mammary glands, ovaries, pituitary, uterus, vagina, spleen, and liver were examined from the top dose and control animals. When it was apparent that possible treatment-related lesions were present in spleens and livers at the top dose, these organs from mid and low dose females were also examined histologically.
* Organs from one female who died on study were inappropriately fixed and could not be examined histologically; therefore n -29. c Number of females with the indicated finding.
in F0 males and females and Fl females, increased in Fl males), expressed as g/day or as g/kg/day during the prebreed periods (selected intervals are presented in Table 1). Treatment-related clinical signs of toxicity included tremors, salivation, slow respiration, mouth breathing, lethargy, staggers, and rooting in bedding (postdosing, presumably from the "taste" of the dosing solution) in F0 males; tremors, ataxia, and convulsions •a 'S « o
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.is (only in animals prior to demise), stupor, abnormal respiration (audible, irregular, raspy, labored), dyspnea, dehydration, excessive urination, bright yellow urine, and rooting in bedding in FO females; tremors, audible breathing, and rooting in bedding in Fl males; and lethargy, abnormal respiration (labored, gasping, and raspy), cyanosis, and rooting in bedding in Fl females (data not shown). There were no further effects on body weights for FO and Fl females during gestation or lactation (Fig.  1) . Maternal feed consumption was significantly reduced for Fl (but not FO) females during gestation (but not lactation) as g/day (Table 1) . At necropsy, FO and Fl males and females exhibited significantly increased absolute and relative spleen weights and significantly increased relative liver weights in Fl males and FO and Fl females ( Table 2) . Hematologic evaluation indicated a consistent picture of anemia, with reduced RBC count, reduced hematocrit, reduced hemoglobin concentration, increased RBC size (MCV), increased nucleated RBC count, increased reticulocyte count, increased MCH (consistent with fewer, larger RBCs), and increased WBC count (with no change in relative differential WBC counts) in FO and Fl males and females, and increased methemoglobin concentration in FO and Fl males (Tables  2 and 3) . Histologically, FO and Fl males and females exhibited splenic congestion and extramedullary hematopoiesis and hemosiderosis and hepatic hemosiderosis and hematopoiesis (Tables 4 and 5 ). Possible evidence of mild testicular effects at 10, 100, and 200 mg/kg/day in the F0 males (Table 4) was clearly not treatment related since these lesions, minimal to mild testicular degeneration and atrophy, were observed with no dose-response pattern in F0 males and were observed in all groups (including the vehicle control group) in Fl males. These findings were also unaccompanied by any changes in relative testis weights. These mild testicular findings are currently frequently observed in CD rat males beginning at 4-5 months of age (Christian et al., 1991) . There were no effects on any other organs, including mammary glands of F0 and Fl females (Table 5) .
At 100 mg/kg/day, no treatment-related mortality occurred. Occasional reductions in body weights and weight gains were observed during the prebreed period in Fl females (Fig. 1) ; occasional changes were observed in feed consumption in FO males (reductions) and Fl males (increases) and females (decreases). Feed consumption during gestation was decreased for Fl (but not F0) females (Table 1) , and no effects during gestation and lactation were noted. Clinical signs of toxicity included lethargy, staggers, and rooting in bedding for F0 males; weaving, tremors, and rooting in bedding in F0 females; slight dehydration, audible breathing, and rooting in bedding in " Data presented as mean ± S.E.M. 'There were 21 females pregnant, but only 20 litters with live pups on pnd 0 (one litter was fully resorbed). Therefore, the n for implantation sites was 21 litters and the n for total and live pups per litter was 20 litters, and the difference in n was responsible for the mean number of implants being lower than the mean number of total pups per litter.
Fl males; and labored breathing in Fl females (data not shown). At necropsy, F0 and Fl males and females exhibited significantly increased absolute and relative spleen weights (Tables 2 and 3 ). Hematologically, again there was a consistent picture of anemia in both sexes in both generations, an increased number of WBC in F0 and Fl males (with no change in differential counts), and an increased methemoglobin concentration (F0 males only) (Tables 2 and 3 ). Livers and spleens of F0 and Fl males and females exhibited extramedullary hematopoiesis and hemosiderosis (Tables 4 and 5) .
At 10 mg/kg/day, there was no treatment-related mortality, and no effects of treatment on body weights, weight gains ( Fig. 1) , or feed consumption (Table 1 ). The only apparent clinical sign of toxicity was rooting in bedding (F0 and Fl males). At necropsy, the only treatment-related observation was dark spleens (5/30) in F0 males only. F0 males only also exhibited reduced RBC count and reduced hemoglobin concentration (Table 3) . Histologically, both spleens and livers exhibited extramedullary hematopoiesis and hemosiderosis (Tables 4 and 5) .
Reproductive Parameters
There were no significant effects of treatment on number of F0 or Fl females, pre-or postbreed, which were cycling, or on cycle length, number of females not cycling, or number of females with abnormal cycles (Table  6 ). There were no effects at any dose for F0 and Fl (a + b) generations for any reproductive indices (Table 7) . Prenatal mortality and stillbirth indices exhibited no significant trends or pairwise comparisons, although there appeared to be slight dose-related increases for both parameters in F0 matings and for stillbirth index only in Fl (a + b) matings. All values for the two parameters in this study were well within the historical control data for the performing laboratory; the overall mean historical prenatal mortality index is 9.7 ± 2.0 (SE) with a range of study mean values of 0.7 ± 0.5-20.4 ± 5.3, and the overall mean historical stillbirth index is 3.7 ± 1.8 with a range of study mean values of 0.3 ± 0.3-10.2 ±5.1.
Offspring Parameters
There were no effects of treatment at any dose on total or live litter size, sex ratio, or pup body weights per litter, with sexes pooled or separate (pnd 0-21) for Fl and F2 (a + b) litters (Table 8 ). There were no treatment-related clinical observations for Fl or F2 (a + b) pups during lactation. There were no treatment-related necropsy findings of pups during lactation or of Fl or F2a pups, 10/ sex/dose, which were necropsied at weaning. There were no treatment-related changes in hematologic parameters or organ weights in Fl or F2a weanlings, 10/sex/dose (data not shown). There were also no histologic effects on Fl, F2a, or F2b weanling female mammary glands (data not shown).
DISCUSSION
The present study evaluated exposure of CD rats to methylethyl ketoxime administered by gavage at 0, 10, 100, or 200 mg/kg/day for two generations, one breed for the first generation and two breeds (the second for initially unsuccessful animals) for the second generation. The increased spleen weights and splenic and hepatic extramedullary hematopoiesis (hematopoietic cell proliferation) and hemosiderosis (pigment deposition from hemoglobin breakdown products) observed were consistent with hemolytic anemia and compensatory erythropoiesis (U.S. EPA, 1989b) . At 100 and 200 mg/kg/day, this anemia may have contributed, at least in part, to the observed reduced body weights and weight gains, reduced feed consumption, and clinical signs of toxicity and may have contributed to the mortality at 200 mg/kg/day. At 10 mg/kg/day, the only consistent finding was the histologic evidence of extramedullary hematopoiesis and hemosiderosis in livers and spleens, essentially unaccompanied by any other indications of toxicity. The most conservative assumption is that the blood effects occurred at this dose level but were not profound enough to result in significantly altered hematopoietic parameters. The hepatic and splenic microscopic examination was sensitive enough to detect the more subtle effects on the hematopoietic system.
There were no effects of treatment on parental reproductive behavior or on parental reproductive organ histology.
There were also no effects of treatment on any offspring parameters, including pre-and postnatal survival and growth, for either generation.
The toxic effects on the adults are consistent with the metabolism of MEKO to hydroxylamine and methylethyl ketone (Black et al., 1991; DeMaster et al., 1992) , with hydroxylamine responsible for the effects on the formed elements of the blood (Cranston and Smith, 1971; Casarett andDoull, 1975; U.S. EPA, 1984a; Derelankoef al., 1987) and resulting mortality (Smith and Layne, 1969) , and methylethyl ketone responsible for the CNS depression (Procter et al., 1988) .
In the presence of overt parental toxicity at 100 and 200 mg/kg/day and of minimal parental toxicity at 10 mg/kg/day, there were no treatment-or dose-related effects on parental reproductive activity or reproductive organ histology or on any offspring parameters assessing pre-and postnatal survival and growth for two generations. Therefore, an adult toxicity "no observable adverse effect level" (NOAEL) was not established in this study; the reproductive and postnatal toxicity NOAEL was at least 200 mg/kg/day in rats under the conditions of this study.
